No information is available for Reference: Effects of drug resistance mutations L100I and V106A on the binding of pyrrolobenzoxazepinone nonnucleoside inhibitors to the human immunodeficiency virus type 1 reverse transcriptase catalytic complex.
No data from this paper has been entered yet. You can create an account to enter it right now if you like.
We welcome new collaborators! Get started by creating an account and entering some data. Please contact us if you would like to contribute more than a few references.